HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: AJPH.2008.144584v1 98/11/1927    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goldsworthy, R. Search for Related Content PubMed Articles by Goldsworthy, R. Related Collections Other Health Financing Influenza

Richard Goldsworthy, PhD

The author is with Academic Edge, Inc, Bloomington, IN.

Correspondence: Requests for reprints should be sent to Richard Goldsworthy, Academic Edge, Inc, 108 E 14th St, Bloomington, IN 47408 (e-mail: rick@academicedge.com).

	Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

Mitchell's letter concerning our study raises an important public health issue related to prescription medication sharing that our study—focused as it was on direct effects on consumers—did not consider: the impact of such sharing on research and evaluation predicated upon prescription data sources. Mitchell is absolutely correct in asserting that there is considerable potential for consumer loaning and borrowing of prescription medication to affect the accuracy of traditional adverse effects reporting systems. We agree that efforts using these sources, whether for ongoing surveillance or as part of clinical trials, may need to take into consideration the potential underreporting of adverse . . . [Full Text]